Euthyroid sick syndrome is a pattern of abnormal thyroid blood tests that appears during serious illness, even though the thyroid gland itself is healthy. The hallmark is a drop in the active thyroid hormone T3, often with changes in T4 and TSH as well, all driven not by thyroid disease but by the body’s response to whatever else is going wrong. It is extremely common in intensive care units and among people hospitalized with conditions like heart failure, sepsis, and major trauma, and it has sparked decades of debate over whether it represents the body wisely conserving energy or an accidental consequence of inflammation that makes things worse.
How the Body Alters Thyroid Hormones During Illness
Under normal circumstances, your thyroid gland produces mostly T4, a relatively inactive hormone. Enzymes called deiodinases then convert T4 into T3, the form your cells actually use for regulating metabolism. During serious illness, this conversion process changes dramatically. The enzymes that produce T3 (known as D1 and D2) become less active, while a third enzyme (D3) that inactivates thyroid hormones ramps up.1Journal of Endocrinology. The molecular basis of the non-thyroidal illness syndrome The net result is less T3 circulating in the blood and more of a metabolically inactive byproduct called reverse T3.
This is only part of the picture. There is also a shift in the brain’s command center for thyroid function. In a healthy person, the hypothalamus releases TRH, which tells the pituitary to release TSH, which in turn tells the thyroid to make hormones. During prolonged critical illness, TRH production in the hypothalamus drops. Research on patients who died from severe nonthyroidal illness found that TRH messenger RNA in the hypothalamus was positively correlated with circulating T3 levels, suggesting that the brain’s signaling to the thyroid gland actively dims during illness rather than ramping up to compensate for falling hormone levels.2The Journal of Clinical Endocrinology & Metabolism. Decreased Hypothalamic Thyrotropin-Releasing Hormone Gene Expression in Patients with Nonthyroidal Illness This central suppression explains why TSH does not rise the way it would in someone with genuine hypothyroidism.
Cytokines, the inflammatory signaling molecules that flood the bloodstream during infection and injury, appear to be key drivers of both the enzyme changes and the central suppression. In laboratory models, cytokines directly reduce the activity of the liver enzyme that converts T4 to T3, creating a self-reinforcing cycle: less T3 means less enzyme production, which means even less T3.3PubMed. Regulation of hepatocyte thyroxine 5′-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome Animal studies have also shown that illness rapidly reduces the expression of thyroid hormone transporter genes in the liver, meaning cells not only make less T3 but also take up less of the T4 available for conversion.4Journal of Endocrinology. Tissue thyroid hormone metabolism is differentially regulated during illness in mice
Triggers Beyond Acute Illness
Severe infection, trauma, surgery, and critical illness are the classic settings, but euthyroid sick syndrome can also appear in situations that have nothing to do with inflammation in the usual sense. Extended fasting is one. During prolonged food scarcity, the body reduces peripheral thyroid hormone metabolism as a way of lowering energy expenditure, while the central hypothalamic-pituitary-thyroid axis remains relatively stable. This shifts the body into a lower metabolic gear that conserves calories.5PubMed Central. The influence of extended fasting on thyroid hormone: local and differentiated regulatory mechanisms The hormonal picture looks similar to what happens in critical illness: T3 falls, reverse T3 rises, and TSH stays inappropriately low or normal.
Certain medications used commonly in hospitals can also mimic or worsen the syndrome. Dopamine, frequently infused to support blood pressure in critically ill patients, suppresses TSH secretion directly at the pituitary. In one study, dopamine infusions in critically ill patients reduced TSH by about half and lowered T4 production by a similar degree compared to patients not receiving the drug. The researchers concluded that dopamine therapy likely prolongs and aggravates the low-T4 state during critical illness.6The Journal of Clinical Endocrinology & Metabolism. Prolonged Dopamine Administration and Thyroid Hormone Economy in Normal and Critically Ill Subject Glucocorticoids, somatostatin analogues, and dopamine agonists can also suppress TSH through similar central mechanisms.7PubMed Central. Drugs that suppress TSH or cause central hypothyroidism For clinicians interpreting thyroid tests at the bedside, separating the effects of illness from the effects of medications can be genuinely difficult.
How Common It Is in Hospitalized Patients
The prevalence depends heavily on what kind of patients you look at and how sick they are. In cardiovascular disease, a systematic review and meta-analysis found that the syndrome was most common in heart failure, affecting roughly one in four patients with that diagnosis. It was somewhat less frequent in acute myocardial infarction (about 19%) and acute coronary syndrome (about 17%).8International Journal of Cardiology. Prevalence and prognostic role of non-thyroidal illness syndrome in cardiovascular disease: A systematic review and meta-analysis A study focused on advanced heart failure patients found an even higher rate: roughly 44% had low T3 levels, and those with worse heart failure markers tended to have lower T3.9PubMed Central. A Critical Investigation of Sick Euthyroid Syndrome in Chronic Heart Failure Patients: Addressing the Need for Accurate Thyroid Assessment
In general ICU populations, the syndrome appears in a substantial minority of admissions, though exact numbers vary by study. A study of patients with acute coronary syndrome found euthyroid sick syndrome in about 10% of the critically ill cohort, and every patient who died during the study had low T3.10PubMed Central. Thyroid Hormone Profile in Patients With Acute Coronary Syndrome In Chinese ICU patients, disease severity scores were positively correlated with levels of reverse T3, meaning sicker patients tended to accumulate more of the inactive thyroid hormone byproduct.11PubMed Central. Relationship between disease severity and thyroid function in Chinese patients with euthyroid sick syndrome
Why Low T3 Tracks With Worse Outcomes
Across many studies, patients with low T3 during critical illness are more likely to die. In one ICU cohort, survivors had significantly higher T3 levels than nonsurvivors, and patients with normal T3 had substantially lower mortality: out of 39 patients with normal T3, only 8 died, compared with 28 deaths among those with low T3.12PubMed Central. Low triiodothyronine predicts mortality in critically ill patients However, the critical question is whether low T3 is itself contributing to the bad outcome or whether it simply reflects how sick the patient is.
A recent study tackled this directly. Low T3 was initially associated with roughly a threefold increase in the odds of in-hospital death. But after adjusting for a standard measure of organ dysfunction (the SOFA score), the link between low T3 and mortality essentially vanished.13Scientific Reports. Early total triiodothyronine, illness severity, and in-hospital mortality in critically ill adults In other words, T3 dropped because the patients were sicker, and it was the severity of illness, not the thyroid hormone deficit per se, that explained the deaths. This finding has important implications for treatment, as it suggests T3 may be more of a bystander marker than a causal player in mortality.
Telling It Apart From True Thyroid Disease
The blood test pattern in euthyroid sick syndrome can look uncomfortably similar to central hypothyroidism, a condition in which the pituitary or hypothalamus fails to produce enough TSH to keep the thyroid working properly. Both conditions can feature low T3 and T4 with a TSH that is low or inappropriately normal. The distinguishing clues are clinical context and cortisol levels: severe euthyroid sick syndrome occurs in the setting of obvious serious illness, and cortisol is typically elevated as part of the stress response. In central hypothyroidism, the illness itself may be less severe and cortisol may be low, especially if the pituitary is broadly failing.14Endocrine Abstracts. Is it euthyroid sick syndrome or central hypothyroidism?
Lab measurement itself adds another layer of confusion. Standard free T4 assays can give unreliable results in critically ill patients. Medications like heparin (used widely as a blood thinner in hospitals) can interfere with the test, and changes in binding proteins during illness can distort the numbers.15PubMed. Free thyroid hormone measurement. A critical appraisal This means a free T4 result read as “low” may not truly be low, and one that reads as “normal” may not truly be normal. Because of these measurement artifacts, most endocrinologists recommend against routinely testing thyroid function in acutely ill hospitalized patients unless there is a specific reason to suspect pre-existing thyroid disease. If tests are drawn, interpreting them requires awareness that the numbers may not mean what they would in an outpatient setting.
Is It Protective or Harmful?
This is arguably the longest-running argument in thyroid endocrinology. On one side, the “adaptive” camp argues that the body deliberately dials down metabolism during illness to reduce oxygen consumption and energy demand, much like a hibernating animal slowing its engine to survive the winter. On the other, the “maladaptive” camp argues that the hormone changes represent collateral damage from inflammation and that the resulting state of tissue-level hypothyroidism impairs recovery.16PubMed. Euthyroid sick syndrome: an overview
The most honest characterization is probably that it is both. A comprehensive review described euthyroid sick syndrome as “a complex mix of physiologic adaptation and pathologic response to acute illness.”17PubMed. Euthyroid Sick Syndrome The early drop in T3 may be a sensible conservation strategy, while the prolonged suppression seen in patients who remain critically ill for weeks may cross the line into something harmful. This distinction matters enormously for treatment decisions, because if the response is protective, giving thyroid hormones could do more harm than good, and if it is harmful, replacing them could save lives.
What the Treatment Trials Show
Given the decades of debate, you might expect a clear answer from clinical trials. Instead, the results have been inconsistent and sometimes alarming. A pair of pilot randomized trials in septic shock patients illustrates this perfectly. Patients were divided based on their hormonal profile: those with low T3 only versus those with both low T3 and low T4. Among the low-T3-only group, giving oral T3 was associated with dramatically worse survival: 75% of treated patients died by day 28, compared with 33% on placebo. But in the group with both low T3 and low T4, the opposite happened: 25% of treated patients died in the ICU versus 52% on placebo, and blood pressure improved significantly.18PubMed. Triiodothyronine hormone supplementation therapy in septic shock patients with euthyroid sick syndrome: two pilot, placebo-controlled, randomized trials These were small pilot studies, and the findings could reflect chance variation, but they underscore a disturbing possibility: thyroid hormone replacement might help some subgroups and harm others, and we do not yet know how to reliably tell them apart.
In pediatric cardiac surgery, the picture is slightly more encouraging. A randomized trial found that giving a small dose of thyroid hormone before surgery in children reduced the severity of euthyroid sick syndrome after the procedure and appeared to protect the heart muscle from injury related to the surgery itself.19PubMed Central. Preoperative oral thyroid hormones to prevent euthyroid sick syndrome and attenuate myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass in children This is a very specific scenario, though, where the illness is planned and time-limited, quite different from open-ended sepsis or chronic heart failure.
One area where thyroid hormone therapy had been widely adopted on weak evidence is brain-dead organ donors. The rationale seemed sound: brain death suppresses the hypothalamus, thyroid hormones drop, and the donor’s heart deteriorates, so replacing the hormones should keep the heart transplantable. But a rigorous randomized trial published in the New England Journal of Medicine tested intravenous levothyroxine against saline in hemodynamically unstable brain-dead potential heart donors and found no difference in the number of hearts transplanted. About 55% of donors in each group yielded transplantable hearts. The levothyroxine group did, however, experience more severe high blood pressure and rapid heart rate.20PubMed Central. Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors A separate trial comparing T3 with T4 infusions in similar donors also found no significant hemodynamic or cardiac benefits from T3.21PubMed. A randomized trial comparing triiodothyronine (T3) with thyroxine (T4) for hemodynamically unstable brain-dead organ donors A comprehensive review of clinical trials in this area concluded that while thyroid hormone supplementation does restore circulating hormone levels in brain-dead donors, improvements in cardiac function and transplant outcomes were inconsistent and most studies failed to show better recipient survival or graft function.22PubMed Central. Thyroid Hormone Therapy for Potential Heart Donors: A Comprehensive Review of Clinical Trials
The overall treatment landscape, then, is one where the lab numbers can be normalized easily enough, but normalizing them does not reliably improve the outcomes that matter. This is consistent with the interpretation that low T3 is primarily a marker of severity rather than a direct cause of deterioration.
Recovery and the TSH Rebound
Thyroid function generally returns to normal as the underlying illness resolves.23PubMed. Thyroid function during critical illness The recovery phase has its own characteristic pattern, which can itself cause diagnostic confusion. TSH levels climb back toward normal and often temporarily overshoot, rising above the standard reference range. T3 and T4 gradually normalize, and reverse T3 falls back down.24PubMed Central. Non-thyroidal illness (euthyroid sick) syndrome: Laboratory aspects and clinical significance in critically ill patients and other diseases – A narrative review
The transient TSH elevation during recovery is clinically significant because it can be misread as subclinical hypothyroidism if blood is drawn at the wrong moment. A patient whose TSH is mildly elevated two weeks after a severe illness might be started on thyroid medication unnecessarily. Most guidelines recommend waiting at least six to eight weeks after recovery from a major illness before drawing thyroid labs for the purpose of diagnosing a thyroid disorder. Checking too early invites false positives and unnecessary treatment.
When It Appears in Newborns
Premature and critically ill newborns are particularly susceptible to thyroid hormone disruption, and this creates a unique diagnostic headache. In premature infants, the hypothalamic-pituitary-thyroid axis is still maturing, so low thyroid hormones may reflect immaturity, illness, or both. In a study of sick term neonates admitted to intensive care, about 10% developed low free T4 levels during their first week. Risk factors included birth complications like oxygen deprivation and the need for prolonged mechanical ventilation, and lower free T4 correlated with longer hospital stays.25PubMed Central. Hypothyroxinemia in sick term neonates and its risk factors in an extramural neonatal intensive care unit: a prospective cohort study
The stakes are higher in newborns because thyroid hormones are essential for brain development during the first months of life. In an adult with euthyroid sick syndrome, a wait-and-see approach makes sense because the hormone changes resolve and the brain is not in a critical growth window. In a newborn, the calculation is different. Prolonged low thyroid hormone levels during a period of rapid neurodevelopment could theoretically cause lasting harm, yet the treatment evidence is not strong enough to support routine supplementation. Neonatal endocrinologists generally handle these cases individually, monitoring hormone levels closely and intervening only when values are severely and persistently low. Standard free T4 assays are even less reliable in neonates than in adults, particularly in sick premature infants, adding yet another layer of measurement uncertainty to an already uncertain clinical picture.